ZA882917B - Method for inhibiting loss of cognitive functions employing an ace inhibitor - Google Patents

Method for inhibiting loss of cognitive functions employing an ace inhibitor

Info

Publication number
ZA882917B
ZA882917B ZA882917A ZA882917A ZA882917B ZA 882917 B ZA882917 B ZA 882917B ZA 882917 A ZA882917 A ZA 882917A ZA 882917 A ZA882917 A ZA 882917A ZA 882917 B ZA882917 B ZA 882917B
Authority
ZA
South Africa
Prior art keywords
ace inhibitor
cognitive functions
inhibiting loss
functions employing
employing
Prior art date
Application number
ZA882917A
Other languages
English (en)
Inventor
Abraham Sudilovsky
Sudilovsky Abraham
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA882917B publication Critical patent/ZA882917B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA882917A 1987-04-27 1988-04-25 Method for inhibiting loss of cognitive functions employing an ace inhibitor ZA882917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4312787A 1987-04-27 1987-04-27

Publications (1)

Publication Number Publication Date
ZA882917B true ZA882917B (en) 1988-12-28

Family

ID=21925639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882917A ZA882917B (en) 1987-04-27 1988-04-25 Method for inhibiting loss of cognitive functions employing an ace inhibitor

Country Status (11)

Country Link
EP (1) EP0288907A3 (fr)
JP (1) JPS63284130A (fr)
KR (1) KR880012220A (fr)
AU (1) AU612137B2 (fr)
CA (1) CA1321753C (fr)
DK (1) DK226488A (fr)
FI (1) FI881972A (fr)
HU (1) HUT46538A (fr)
IL (1) IL85987A (fr)
PH (1) PH23871A (fr)
ZA (1) ZA882917B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
IL90189A0 (en) * 1988-06-01 1989-12-15 Squibb & Sons Inc Pharmaceutical compositions containing a benzazepine-type calcium channel blocker
CA2019324C (fr) * 1989-07-10 1996-08-20 Robert L. Jerzewski Comprimes de fosinopril
FR2655989B1 (fr) * 1989-12-20 1992-02-28 Adir Nouveaux derives d'amino-acides substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5179113A (en) * 1990-03-20 1993-01-12 E. I. Du Pont De Nemours And Company Treatment of central nervous disorders with imidazole compounds
US5173494A (en) * 1990-03-20 1992-12-22 E. I. Du Pont De Nemours And Company Specific inhibition of angiotensin-II binding to angiotensin-II receptor subtype-2
US5140037A (en) 1990-03-20 1992-08-18 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
US5137906A (en) * 1990-03-20 1992-08-11 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonists
US5155126A (en) * 1990-03-20 1992-10-13 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
US5098889A (en) * 1990-09-17 1992-03-24 E. R. Squibb & Sons, Inc. Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5091390A (en) * 1990-09-20 1992-02-25 E. I. Du Pont De Nemours And Company Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555506A (en) * 1981-12-24 1985-11-26 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and use as hypotensives
US4427665A (en) * 1982-05-19 1984-01-24 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted imino acids and their use in hypotensive compositions
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
DE3610391A1 (de) * 1986-03-27 1987-10-08 Hoechst Ag Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Also Published As

Publication number Publication date
PH23871A (en) 1989-12-18
EP0288907A2 (fr) 1988-11-02
DK226488A (da) 1988-10-28
HUT46538A (en) 1988-11-28
FI881972A0 (fi) 1988-04-27
KR880012220A (ko) 1988-11-26
AU612137B2 (en) 1991-07-04
IL85987A0 (en) 1988-09-30
IL85987A (en) 1992-05-25
JPS63284130A (ja) 1988-11-21
CA1321753C (fr) 1993-08-31
EP0288907A3 (fr) 1991-01-30
DK226488D0 (da) 1988-04-26
FI881972A (fi) 1988-10-28
AU1355688A (en) 1988-10-27

Similar Documents

Publication Publication Date Title
GB8813372D0 (en) Inhibitors of neutral endopeptidase
PT81965A (en) Process for the preparation of novel peptidase inhibitors
IL88273A0 (en) Renin inhibitors
EP0281742A3 (en) Method for verifying spelling of compound words
CS253388A2 (en) Method of 10-dihydro-10-dexy-11-azarythronolides prepararation
PL287114A1 (en) Method of obtaining retroviral proteases inhibitors
HU893412D0 (en) Inhibitors of interleucin-1
ZA881804B (en) Method of inhibiting interleukin-1 release
EP0230597A3 (en) Method for inhibiting polymerization of maleimides
ZA882917B (en) Method for inhibiting loss of cognitive functions employing an ace inhibitor
EP0426066A3 (en) Ace inhibitors for use for preventing onset of type ii diabetes
EP0137445A3 (en) Process for c-methylation of 2-methylbutyrates
GB8901675D0 (en) Inhibitor of gene expression
AU2640488A (en) Method for preventing or treating anxiety employing an ace inhibitor
ZA871442B (en) Machine-pistol for cartridges of different types
EP0411395A3 (en) Use of ace inhibitors for atherosclerosis-prophylaxis
GB2196991B (en) Method for removal of patina
ZA888866B (en) Method for preventing or treating anxiety employing an ace inhibitor
IE862859L (en) INHIBITORS OF DOPAMINE-ß-HYDROXYLASE
EP0418582A3 (en) Method for treating hypermotility diseases of the bowel employing an ace inhibitor
HUT37602A (en) Process for peoduction of dopamin-beta-hydrixilaze inhibitors of derivatives of marcapto-imidasole
CS274683B2 (en) Method of dialkyldichlorosuccinates
BG45622A1 (en) Method for prepraing of polyethylentherephthalate
BG46662A1 (en) Inhibitor of urease
ZA907727B (en) Inhibitors of retroviral proteases